Skip to search formSkip to main contentSkip to account menu

losmapimod

Known as: GW-856553X, GW856553X, 3-pyridinecarboxamide, 6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-n-(2,2-dimethylpropyl)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Single doses of p 38 MAP kinase inhibitors or prednisolone affect CRP and IL-6 in patients with active Rheumatoid Arthritis ( RA )
Purpose: To investigate the effects of single doses of losmapimod, dilmapimod (inhibitors of p38 MAPK) and prednisolone on… 
2013
2013
Losmapimod concentration–QT relationship in healthy volunteers: meta-analysis of data from six clinical trials
The objective of this work was to describe the losmapimod concentration–QT relationship using meta-analysis of data from clinical… 
2011
2011
Synthesestrategie, polymorphe Eigenschaften und Struktur-Aktivitäts-Beziehungen von Sunitinib, Losmapimod, Roflumilast und strukturverwandten Wirkstoffen